back to Australia directory
australia clinical guidance

Type 2 diabetes

A detailed Australian summary of type 2 diabetes, with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Confirm diabetes using an accepted laboratory criterion and repeat an asymptomatic abnormal result on another day unless unequivocal hyperglycaemia is present. Set an individual glycaemic target after considering age, hypoglycaemia, comorbidity, complications, treatment burden, life expectancy and the person鈥檚 priorities. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:RACGP/Diabetes Australia T2D

The Bottom Line

  • Confirm diabetes using an accepted laboratory criterion and repeat an asymptomatic abnormal result on another day unless unequivocal hyperglycaemia is present.
  • Set an individual glycaemic target after considering age, hypoglycaemia, comorbidity, complications, treatment burden, life expectancy and the person鈥檚 priorities.
  • Use an accredited diabetes educator and dietitian to support glucose monitoring, nutrition and medicine skills rather than relying on brief advice.
  • Medicine choice should consider cardiovascular disease, heart failure, chronic kidney disease, weight, hypoglycaemia risk, kidney function, cost and PBS access.
sources for this section:RACGP/Diabetes Australia T2D

Practical clinical workflow

1

Topic-specific assessment action

Confirm diabetes using an accepted laboratory criterion and repeat an asymptomatic abnormal result on another day unless unequivocal hyperglycaemia is present.
2

Topic-specific diagnostic action

Medicine choice should consider cardiovascular disease, heart failure, chronic kidney disease, weight, hypoglycaemia risk, kidney function, cost and PBS access.
3

Topic-specific management action

At structured review, cover blood pressure, lipids, kidney markers, feet, retinal screening, smoking, vaccination, nutrition, activity and emotional wellbeing.
4

Topic-specific follow-through

Review B12 when long-term metformin exposure and anaemia or neuropathy make deficiency plausible.
sources for this section:RACGP/Diabetes Australia T2D

Safety boundaries and escalation

  • Provide sick-day and hypoglycaemia education, and urgently assess ketosis, dehydration, vomiting, altered consciousness or hyperglycaemic emergency features.
  • Before SGLT2 inhibitor use, explain perioperative and fasting holds and euglycaemic ketoacidosis symptoms.
sources for this section:RACGP/Diabetes Australia T2D

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:RACGP/Diabetes Australia T2D

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:RACGP/Diabetes Australia T2D

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Royal Australian College of General Practitioners and Diabetes AustraliaManagement of type 2 diabetes: A handbook for general practice2024 living web edition 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.